Letter To Editor Trump For India?

President Donald Trump's announcement of the United States' withdrawal from WHO presents significant challenges to global health governance and international cooperation, and the retraction could lead the U.S. to isolate its health system considerably. As one of the world's largest funders of global health through, both international and national agencies, trump back-pedalling may curtail efforts to provide lifesaving health care and combat deadly outbreaks, especially in lower-income countries without the means to do so alone. As for India, key programmes, such as tuberculosis eradication and vaccine distribution could entail significant delays and reduced funding if the global health body's resources are stretched thin. Moreover, the absence of US support might slow down collaborative efforts between Indian organizations and the WHO, potentially impacting initiatives aimed at tackling antimicrobial resistance, improving maternal and child health, and strengthening general health systems.

As the global healthcare community navigates this development, stakeholders in India must prioritize resilience and collaboration. Strengthening domestic public health initiatives, investing in indigenous research and development, and fostering multilateral partnerships will be crucial to mitigating the fallout of reduced WHO funding. While the US withdrawal is a significant setback, it also serves as a reminder of the need for collective action and robust frameworks to address global health challenges effectively.

Ranganathan Sivakumar

Gandhi Nagar, Tamil Nadu

MENAFN06022025000215011059ID1109178325